Home » Stocks » GTHP

Guided Therapeutics, Inc. (GTHP)

Stock Price: $0.405 USD 0.080 (24.62%)
Updated Oct 20, 2020 12:51 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 5.30M
Revenue (ttm) 17,000
Net Income (ttm) -3.09M
Shares Out 13.10M
EPS (ttm) -0.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $0.405
Previous Close $0.325
Change ($) 0.080
Change (%) 24.62%
Day's Open 0.340
Day's Range 0.340 - 0.405
Day's Volume 957
52-Week Range 0.1005 - 0.58

More Stats

Market Cap 5.30M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 13.10M
Float 6.67M
EPS (basic) n/a
EPS (diluted) -0.53
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.84
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 312.00
PB Ratio n/a
Revenue 17,000
Operating Income n/a
Net Income -3.09M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin -200.00%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -100.15%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name Guided Therapeutics, Inc.
Country United States
Employees 5
CEO Gene S. Cartwright

Stock Information

Ticker Symbol GTHP
Stock Exchange US OTC
Sector Healthcare
Industry Medical Devices
Unique Identifier OTCMKTS: GTHP
IPO Date July 1, 1997

Description

Guided Therapeutics, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.